Kåvepenin Frukt (Phenoxymethylpenicillin Potassium)

Kåvepenin Frukt is a penicillin antibiotic used to treat infections caused by susceptible bacteria.

• Streptococcal pharyngitis: eradicates Streptococcus pyogenes and relieves throat pain.
• Tonsillitis: clears bacterial infection of the tonsils and reduces inflammation.
• Skin and soft‑tissue infections: treats cellulitis, impetigo and other infections caused by susceptible Gram‑positive organisms.
• Mild to moderate respiratory tract infections: resolves bacterial bronchitis or sinusitis symptoms.

• Phenoxymethylpenicillin potassium binds to penicillin‑binding proteins on the bacterial cell membrane, inhibiting the transpeptidation step of peptidoglycan synthesis. This prevents cross‑linking of the bacterial cell wall, leading to weakened walls and eventual lysis of susceptible Gram‑positive organisms.

Adverse reactions may occur with any antibiotic. Most are mild and reversible, but serious events require immediate medical attention.

Common Side Effects

• Nausea: mild stomach upset after oral intake.
• Diarrhea: loose stools, often self‑limiting.
• Rash: mild skin erythema or itching.
• Taste disturbance: temporary alteration of taste perception.
• Abdominal pain: cramping or discomfort.
• Mild allergic reactions: localized hives or itching.

Serious or Rare Side Effects

• Anaphylaxis: severe, potentially life‑threatening allergic reaction.
• Stevens‑Johnson syndrome: rare severe skin blistering.
• Clostridioides difficile‑associated diarrhea: severe colitis after disruption of gut flora.
• Hemolytic anemia: destruction of red blood cells.
• Serum sickness‑like reaction: fever, joint pain, rash.
• Severe liver injury: jaundice, elevated liver enzymes.

Before prescribing Kåvepenin Frukt, clinicians should assess patient history and monitor for specific risks.

• Allergy assessment: avoid in patients with known penicillin hypersensitivity.
• Renal function: adjust dose in patients with impaired kidney function.
• Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation.
• Concomitant antibiotics: avoid simultaneous use with bacteriostatic agents that may antagonize effect.
• Superinfection risk: monitor for signs of fungal or secondary bacterial infection.
• Store at ambient temperature below 25°C: keep in original packaging, protect from moisture and direct sunlight.

Phenoxymethylpenicillin potassium can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid)

• Methotrexate: increased toxicity and bone‑marrow suppression.
• Oral contraceptives: reduced hormonal efficacy, risk of unintended pregnancy.
• Allopurinol: heightened risk of skin rash.

Moderate Interactions (Monitor Closely)

• Probenecid: raises penicillin plasma concentrations, may require dose adjustment.
• Tetracyclines: antagonistic effect reducing antibacterial activity.
• Warfarin: possible alteration of INR, monitor coagulation parameters.